Orapi SA
PAR:ORAP

Watchlist Manager
Orapi SA Logo
Orapi SA
PAR:ORAP
Watchlist
Price: 6.5 EUR
Market Cap: 43.2m EUR
Have any thoughts about
Orapi SA?
Write Note
Section:
 

Relative Value

The Relative Value of one ORAP stock under the Base Case scenario is 21.87 EUR. Compared to the current market price of 6.5 EUR, Orapi SA is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORAP Relative Value
Base Case
21.87 EUR
Undervaluation 70%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.1
P/S
P/S
Price to Sales
0.1
vs History
66
vs Industry
95
Median 3Y
0.1
Median 5Y
0.1
Industry
1.5
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
10
Median 3Y
-1.3
Median 5Y
5.1
Industry
21.7
Forward
8.2
More Details
2.5
P/OCF
P/OCF
Price to OCF
2.5
vs History
33
vs Industry
75
Median 3Y
2.3
Median 5Y
2.1
Industry
13
More Details
3.3
P/FCFE
P/FCFE
Price to FCFE
3.3
vs History
34
vs Industry
54
Median 3Y
3.3
Median 5Y
2.3
Industry
20.5
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
0
vs Industry
68
Median 3Y
0.7
Median 5Y
0.7
Industry
1.6
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
63
vs Industry
85
Median 3Y
0.3
Median 5Y
0.3
Industry
1.6
Forward
0.4
More Details
0.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.9
vs History
63
vs Industry
87
Median 3Y
1
Median 5Y
1
Industry
7.2
More Details
7.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.1
vs History
9
vs Industry
55
Median 3Y
4.9
Median 5Y
4.2
Industry
13.2
Forward
4.7
More Details
132.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
132.6
vs History
0
vs Industry
2
Median 3Y
13.3
Median 5Y
12.4
Industry
17.5
Forward
12.1
More Details
6.1
EV/OCF
EV/OCF
Enterprise Value to OCF
6.1
vs History
33
vs Industry
65
Median 3Y
5
Median 5Y
4.8
Industry
13.9
More Details
9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9
vs History
38
vs Industry
43
Median 3Y
9
Median 5Y
8.2
Industry
19.1
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
0
vs Industry
69
Median 3Y
0.6
Median 5Y
0.6
Industry
1.3
More Details

Multiples Across Competitors

ORAP Competitors Multiples
Orapi SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Orapi SA
PAR:ORAP
42.3m EUR 0.1 -1.3 7.1 132.6
US
Sherwin-Williams Co
NYSE:SHW
87.3B USD 3.8 34.1 22.1 25.7
US
Ecolab Inc
NYSE:ECL
68.5B USD 4.4 33.5 21.3 29.1
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.3T JPY 4.1 20 8.9 11.7
CH
Givaudan SA
SIX:GIVN
36.4B CHF 5.1 35.3 24.7 31.5
US
Dupont De Nemours Inc
NYSE:DD
32.3B USD 2.6 40.4 12.7 21.1
CN
Wanhua Chemical Group Co Ltd
SSE:600309
230.2B CNY 1.2 15.1 16.6 16.6
US
PPG Industries Inc
NYSE:PPG
28.1B USD 1.6 18.9 11.5 14.2
CH
DSM-Firmenich AG
AEX:DSFIR
26.1B EUR 2.5 12.2 30.9 -60.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.3 47.9 32.5 37.7
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
P/E Multiple
Earnings Growth P/E to Growth
FR
Orapi SA
PAR:ORAP
Average P/E: 31.2
Negative Multiple: -1.3 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
34.1
52%
0.7
US
Ecolab Inc
NYSE:ECL
33.5
76%
0.4
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
20
40%
0.5
CH
Givaudan SA
SIX:GIVN
35.3
46%
0.8
US
Dupont De Nemours Inc
NYSE:DD
40.4
399%
0.1
CN
Wanhua Chemical Group Co Ltd
SSE:600309
15.1
41%
0.4
US
PPG Industries Inc
NYSE:PPG
18.9
80%
0.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
12.2
-42%
N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
47.9
7%
6.6
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Orapi SA
PAR:ORAP
Average EV/EBITDA: 19.7
7.1
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
22.1
27%
0.8
US
Ecolab Inc
NYSE:ECL
21.3
38%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
8.9
36%
0.2
CH
Givaudan SA
SIX:GIVN
24.7
34%
0.7
US
Dupont De Nemours Inc
NYSE:DD
12.7
32%
0.4
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.6
131%
0.1
US
PPG Industries Inc
NYSE:PPG
11.5
21%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
30.9
203%
0.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
32.5
10%
3.2
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Orapi SA
PAR:ORAP
Average EV/EBIT: 35.8
132.6
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
25.7
34%
0.8
US
Ecolab Inc
NYSE:ECL
29.1
52%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.7
N/A N/A
CH
Givaudan SA
SIX:GIVN
31.5
44%
0.7
US
Dupont De Nemours Inc
NYSE:DD
21.1
83%
0.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.6
39%
0.4
US
PPG Industries Inc
NYSE:PPG
14.2
28%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
Negative Multiple: -60.5 N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
37.7
5%
7.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A

See Also

Summary
ORAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORAP stock valuation using valuation multiples.
Wall Street Estimates
ORAP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.